본문 바로가기

EU · EudraLex Vol.4

EU GMP Annex 1 8.85

8. Production and Specific Technologies › Filter sterilisation of products which cannot be sterilised in their final container

조항 원문

Filtration parameters that should be considered and established during validation should include, but are not limited to:

i. The wetting fluid used for filter integrity testing:

• It should be based on the filter manufacturer’s recommendation or the fluid to be filtered. The appropriate integrity test value specification should be established.

• If the system is flushed or integrity tested in-situ with a fluid other than the product, appropriate actions are taken to avoid any deleterious effect on product quality.

ii. Filtration process conditions including:

• Fluid pre-filtration holding time and effect on bioburden.

• Filter conditioning, with fluid if necessary.

• Maximum filtration time/total time filter is in contact with the fluid.

• Maximum operating pressure.

• Flow rate.

• Maximum filtration volume.

• Temperature.

• The time taken to filter a known volume of bulk solution and the pressure difference to be used across the filter.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

출처: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · 수집일 2026-11-15

Weekly Newsletter

이런 지적, 매주 월요일 한국어로 받아보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

매주 월요일 발송 · 구독 신청 시 확인 메일이 발송됩니다 · 수신거부는 모든 메일 하단에서 가능합니다.